Literature DB >> 10615995

Cryoglobulinemic vasculitis.

P Lamprecht1, A Gause, W L Gross.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10615995     DOI： 10.1002/1529-0131(199912)42:12<2507::AID-ANR2>3.0.CO;2-#

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  36 in total

Review 1.  Perspective on future therapy of vasculitis.

Authors:  D T Boumpas; H D Kritikos; N G Daskalakis
Journal:  Curr Rheumatol Rep       Date:  2000-10       Impact factor: 4.592

2.  A randomized controlled trial of rituximab following failure of antiviral therapy for hepatitis C virus-associated cryoglobulinemic vasculitis.

Authors:  Michael C Sneller; Zonghui Hu; Carol A Langford
Journal:  Arthritis Rheum       Date:  2012-03

Review 3.  [Therapy of primary systemic vasculitis].

Authors:  K de Groot; W L Gross; B Hellmich
Journal:  Internist (Berl)       Date:  2003-12       Impact factor: 0.743

Review 4.  Infectious serologies and autoantibodies in hepatitis C and autoimmune disease-associated mixed cryoglobulinemia.

Authors:  Merav Lidar; Noga Lipschitz; Nancy Agmon-Levin; Pnina Langevitz; Ori Barzilai; Maya Ram; Bat-Sheba Porat-Katz; Nicola Bizzaro; Jan Damoiseaux; Jan Willem Cohen Tervaert; Salvatore deVita; Stefano Bombardieri; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2012-04       Impact factor: 8.667

Review 5.  Cryoglobulins.

Authors:  C Ferri; A L Zignego; S A Pileri
Journal:  J Clin Pathol       Date:  2002-01       Impact factor: 3.411

6.  Immunological and clinical follow up of hepatitis C virus associated cryoglobulinaemic vasculitis.

Authors:  P Lamprecht; F Moosig; A Gause; K Herlyn; E Csernok; H Hansen; W L Gross
Journal:  Ann Rheum Dis       Date:  2001-04       Impact factor: 19.103

Review 7.  Cellular targeting in autoimmunity.

Authors:  Jennifer L Rogers; Donald S Serafin; Roman G Timoshchenko; Teresa K Tarrant
Journal:  Curr Allergy Asthma Rep       Date:  2012-12       Impact factor: 4.806

Review 8.  Spontaneous and antiviral-induced cutaneous lesions in chronic hepatitis B virus infection.

Authors:  Ioana Grigorescu; Dan Lucian Dumitrascu
Journal:  World J Gastroenterol       Date:  2014-11-14       Impact factor: 5.742

9.  Decline of cellular activation in non-B cells after rituximab treatment in hepatitis C-associated mixed cryoglobulinemia vasculitis.

Authors:  B Emmanuel; N Sidique; X Zhang; B Poonia; M C Sneller; S Kottilil
Journal:  J Viral Hepat       Date:  2016-09-25       Impact factor: 3.728

10.  Cryoglobulinaemia type III with severe neuropathy and immune complex glomerulonephritis: remission after plasmapheresis and rituximab.

Authors:  Anke Braun; Thomas Neumann; Peter Oelzner; Gert Hein; Hermann-Josef Gröne; Mirjana Ziemer; Gunter Wolf
Journal:  Rheumatol Int       Date:  2007-10-09       Impact factor: 2.631
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.